AI assistant
Sending…
RESMED INC — Director's Dealing 2013
May 24, 2013
30071_dirs_2013-05-24_493776de-9e4e-46d7-aa96-f337ab588693.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-01-31
Reporting Person: QUINN MICHAEL A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-01-31 | ResMed Chess Depositary Instruments | J | 90000 | — | Disposed | 90000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 344000 | Direct |
| ResMed Chess Depositary Instruments | 310000 | Direct |
| ResMed Chess Depositary Instruments | 306000 | Indirect |
Footnotes
F1: These shares are held as CDIs on the Australian Securities Exchange which represents 40,000 NYSE shares. 1 NYSE share is equal to 10 CDIs.
F2: These shares are held as CDIs on the Australian Securities Exchange which represents 30,600 NYSE shares. 1 NYSE share is equal to 10 CDIs.
F3: Transfer of Chess Depositary Instruments to spouse for tax planning purposes. Consideration was $4.33 per CDI. Ten CDIs are equal to 1 NYSE share.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29